TTY Biopharm Financials
| 4105 Stock | TWD 74.00 0.40 0.54% |
TTY |
Understanding current and past TTY Biopharm Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of TTY Biopharm's financial statements are interrelated, with each one affecting the others. For example, an increase in TTY Biopharm's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in TTY Biopharm's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of TTY Biopharm Co. Check TTY Biopharm's Beneish M Score to see the likelihood of TTY Biopharm's management manipulating its earnings.
TTY Biopharm Stock Summary
TTY Biopharm competes with Tehmag Foods, Ibase Gaming, Founding Construction, Hunya Foods, and ReaLy Development. TTY Biopharm Company Limited, together with its subsidiaries, produces various pharmaceuticals and chemical drugs in Taiwan and internationally. The company was founded in 1960 and is headquartered in Taipei City, Taiwan. TTY BIOPHARM is traded on Taiwan OTC Exchange in Taiwan.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004105002 |
| Business Address | No3-1, Park Street, |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | eng.tty.com.tw |
| Phone | 886 2 2652 5999 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in TTY Biopharm without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of TTY Stock, because this is throwing your money away. Analyzing the key information contained in TTY Biopharm's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
TTY Biopharm Key Financial Ratios
There are many critical financial ratios that TTY Biopharm's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that TTY Biopharm reports annually and quarterly.TTY Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TTY Biopharm's current stock value. Our valuation model uses many indicators to compare TTY Biopharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TTY Biopharm competition to find correlations between indicators driving TTY Biopharm's intrinsic value. More Info.TTY Biopharm Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.39 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for TTY Biopharm Co is roughly 2.54 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TTY Biopharm's earnings, one of the primary drivers of an investment's value.TTY Biopharm Systematic Risk
TTY Biopharm's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. TTY Biopharm volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on TTY Biopharm correlated with the market. If Beta is less than 0 TTY Biopharm generally moves in the opposite direction as compared to the market. If TTY Biopharm Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one TTY Biopharm is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of TTY Biopharm is generally in the same direction as the market. If Beta > 1 TTY Biopharm moves generally in the same direction as, but more than the movement of the benchmark.
TTY Biopharm November 28, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of TTY Biopharm help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TTY Biopharm Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of TTY Biopharm Co based on widely used predictive technical indicators. In general, we focus on analyzing TTY Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TTY Biopharm's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.5533 | |||
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 2.55 | |||
| Value At Risk | (0.68) | |||
| Potential Upside | 0.6831 |
Additional Tools for TTY Stock Analysis
When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.